The table below shows Eterna Therapeutics Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
$487.00K
$47.00K
Cost of revenue
-
-
-
-
-$60.00K
$95.00K
Gross profit
-
-
-
-
$547.00K
-$48.00K
R&D
-
-
-
-
-
-
SG&A
ERNA annual revenue (10-K history)
Eterna Therapeutics Inc. reported annual revenue of $582.00K for fiscal year 2024. That is up 755.9% from $68.00K in fiscal 2023. Over the 10 fiscal years shown, annual revenue declined from $26.05M (FY 2014) to $582.00K. Figures come from the company's audited annual reports as filed with the SEC.